ReviewDiabetology & metabolic syndrome2025
Poor glycemic control and microvascular complications: key drivers of depressive symptoms in adults with diabetes.
Review in Diabetology & metabolic syndrome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsTo analyze the association between depressive symptoms and diabetes complications, stratified by metabolic control, in Mexican adults with type 2 diabetes mellitus. MATERIALS AND
methodsWe analyzed data from adults aged 20 years and older with self-reported diabetes from the 2018-2019 Mexican National Health and Nutrition Survey (ENSANUT). Diabetes complications were categorized as microvascular, macrovascular, or other. Metabolic control was defined based on glycated hemoglobin, blood pressure, and cholesterol levels. Depressive symptoms were assessed using the CES-D7 scale. Logistic regression models were stratified by metabolic control to determine the association between complications and depressive symptoms, adjusting for relevant covariates.
resultsAmong adults with poor metabolic control, depressive symptoms were significantly more prevalent in those with complications (47.2%, 95% CI: 46.4-53.9) than in those without (27.9%, 95% CI: 24.4-31.7). Among individuals with good metabolic control, the prevalence of depressive symptoms was higher in those with complications (48.8%, 95% CI: 34.6-63.2) than in those without (31.3%, 95% CI: 23.6-40.2), although the difference was not statistically significant. In those with poor metabolic control, both microvascular and other complications were significantly associated with depressive symptoms (adjusted odds ratios [
conclusionsPoor metabolic control is associated with a higher prevalence of depressive symptoms, especially in patients with microvascular complications. These findings highlight the importance of integrating mental health screening and intervention into diabetes care to support emotional well-being and prevent adverse outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.